Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
- PMID: 32444414
- PMCID: PMC7509518
- DOI: 10.1136/annrheumdis-2020-217522
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
Keywords: autoantibodies; autoimmune diseases; dermatomyositis.
Conflict of interest statement
Competing interests: JAL reports grants from The Myositis Association, grants from Medical Research Council (MR/N003322/1), during the conduct of the study; grants from MedImmune, outside the submitted work.
Figures

Comment in
-
Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future.Ann Rheum Dis. 2022 Oct;81(10):e192. doi: 10.1136/annrheumdis-2020-218594. Epub 2020 Aug 5. Ann Rheum Dis. 2022. PMID: 32759260 No abstract available.
-
Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al.Ann Rheum Dis. 2022 Oct;81(10):e193. doi: 10.1136/annrheumdis-2020-218712. Epub 2020 Aug 5. Ann Rheum Dis. 2022. PMID: 32759262 No abstract available.
-
SARS-CoV-2-associated myopathy with positive anti-Mi-2 antibodies: a case report.Hong Kong Med J. 2023 Apr;29(2):170-172. doi: 10.12809/hkmj219938. Epub 2023 Mar 17. Hong Kong Med J. 2023. PMID: 36927671 No abstract available.
References
-
- Megremis S, Walker TDJ, He X, et al. . Microbial and autoantibody immunogenic repertoires in TIF1γ autoantibody positive dermatomyositis. BioRXiv 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous